Open AccessIncidence of Newly Registered Blindness From Age-Related Macular Degeneration in Australia Over a 21-Year Period
Author(s) -
Rachael C. Heath Jeffery,
Syed Aqif Mukhtar,
Derrick Lopez,
David B. Preen,
Ian L. McAllister,
David A. Mackey,
Nigel Morlet,
William H. Morgan,
Fred K. Chen
Publication year - 2021
Publication title -
asia-pacific journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.163
H-Index - 20
ISSN - 2162-0989
DOI - 10.1097/apo.0000000000000415
Subject(s) - macular degeneration , medicine , incidence (geometry) , verteporfin , visual acuity , aflibercept , ranibizumab , bevacizumab , observational study , ophthalmology , blindness , optometry , pediatrics , choroidal neovascularization , surgery , chemotherapy , physics , optics
Report the age-standardized annual incidence of blindness registration due to age-related macular degeneration (AMD) in Australia in patients aged 50 years and older. Frequencies of photodynamic therapy (PDT) and intravitreal therapy (IVT) were examined.